Clinical Trial

Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy

Completed
View on ClinicalTrials.gov →
Summary
The proposed randomized control trial will evaluate auricular point acupressure (APA) on chemotherapy-induced neuropathy (CIN), rigorously considering point specificity and placebo effects by integrating self-report measures, psychophysical measures (QST), endogenous biomarkers (cytokines), and neuro-imaging to investigate APA's efficacy and underlying mechanism(s).
Protocol Amendment History 3 changes
critical Trial completed 2026-08-05
critical Primary endpoint(s) modified 2026-08-05
minor Completion moved earlier: 2026-05-30 -> 2026-03-19 2026-08-05
Trial Details
NCT Number NCT04920097
Lead Sponsor The University of Texas Health Science Center, Houston
Collaborators: National Cancer Institute (NCI), Johns Hopkins University
Conditions Chemotherapy-induced Neuropathy
Enrollment 238 participants
Start Date 2021-07-08
Primary Completion 2025-05-30 (estimated)
Study Completion 2026-03-19 (estimated)
Updated on ClinicalTrials.gov 2026-08-04